HighMark Wealth Management LLC Acquires 18,000 Shares of Evolent Health, Inc $EVH

HighMark Wealth Management LLC increased its holdings in Evolent Health, Inc (NYSE:EVH) by 55.8% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 50,275 shares of the technology company’s stock after buying an additional 18,000 shares during the quarter. HighMark Wealth Management LLC’s holdings in Evolent Health were worth $566,000 at the end of the most recent reporting period.

Several other large investors also recently added to or reduced their stakes in the business. Parallel Advisors LLC boosted its stake in shares of Evolent Health by 82.6% during the 2nd quarter. Parallel Advisors LLC now owns 3,487 shares of the technology company’s stock worth $39,000 after acquiring an additional 1,577 shares during the last quarter. Banque Cantonale Vaudoise bought a new stake in Evolent Health during the first quarter valued at about $25,000. Rhumbline Advisers increased its position in Evolent Health by 2.1% in the first quarter. Rhumbline Advisers now owns 169,918 shares of the technology company’s stock worth $1,609,000 after buying an additional 3,527 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its stake in shares of Evolent Health by 2.9% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 128,527 shares of the technology company’s stock worth $1,217,000 after buying an additional 3,572 shares during the period. Finally, US Bancorp DE lifted its position in shares of Evolent Health by 291.0% during the 1st quarter. US Bancorp DE now owns 5,153 shares of the technology company’s stock valued at $49,000 after buying an additional 3,835 shares in the last quarter.

Evolent Health Price Performance

Shares of NYSE:EVH opened at $7.87 on Friday. The company has a debt-to-equity ratio of 0.72, a quick ratio of 1.01 and a current ratio of 1.01. The firm has a market cap of $924.21 million, a price-to-earnings ratio of -4.89 and a beta of 0.66. The firm has a fifty day moving average price of $9.20 and a 200 day moving average price of $9.44. Evolent Health, Inc has a fifty-two week low of $7.06 and a fifty-two week high of $27.42.

Evolent Health (NYSE:EVH) last released its quarterly earnings data on Thursday, August 7th. The technology company reported ($0.10) EPS for the quarter, missing the consensus estimate of $0.10 by ($0.20). The company had revenue of $444.33 million for the quarter, compared to the consensus estimate of $459.43 million. Evolent Health had a negative net margin of 5.94% and a positive return on equity of 1.83%. The firm’s revenue for the quarter was down 31.3% on a year-over-year basis. During the same period last year, the company earned $0.30 EPS. Evolent Health has set its Q3 2025 guidance at EPS. As a group, sell-side analysts expect that Evolent Health, Inc will post 0.08 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several research firms recently issued reports on EVH. Canaccord Genuity Group reissued a “buy” rating and issued a $16.00 target price on shares of Evolent Health in a report on Tuesday, September 9th. Truist Financial upped their price target on shares of Evolent Health from $14.00 to $16.00 and gave the stock a “buy” rating in a research report on Thursday, July 17th. BTIG Research restated a “buy” rating and set a $20.00 price objective on shares of Evolent Health in a research report on Tuesday. Stephens restated an “equal weight” rating and set a $9.00 target price on shares of Evolent Health in a research note on Wednesday, September 24th. Finally, Piper Sandler upped their target price on shares of Evolent Health from $16.00 to $18.00 and gave the stock an “overweight” rating in a report on Thursday, August 28th. One equities research analyst has rated the stock with a Strong Buy rating, twelve have issued a Buy rating and one has given a Hold rating to the stock. According to data from MarketBeat, the company has an average rating of “Buy” and an average target price of $17.21.

About Evolent Health

Evolent Health, Inc, through its subsidiary, Evolent Health LLC, offers specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company provides platform for health plan administration and value-based business infrastructure. It offers administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients.